What's new

Clinical human trials begin for COVID-19 vaccine in China

Mass COVID-19 vaccination begins in Azerbaijan
Source: Xinhua| 2021-01-18 20:57:43|Editor: huaxia

139677882_16109768779801n.jpg
A medical worker displays China's Sinovac COVID-19 vaccine before the vaccination at a hospital in Baku, Azerbaijan, Jan. 18, 2021. Azerbaijan's senior health officials on Monday took their first inoculations of a vaccine made by Chinese biopharmaceutical company Sinovac Biotech, marking the beginning of mass vaccination against COVID-19 in the country, according to state-run news agency AZERTAC. (Photo by Tofik Babayev/Xinhua)

BAKU, Jan. 18 (Xinhua) -- Azerbaijan's senior health officials on Monday took their first inoculations of a vaccine made by Chinese biopharmaceutical company Sinovac Biotech, marking the beginning of mass vaccination against COVID-19 in the country, according to state-run news agency AZERTAC.

Azerbaijani Health Minister Ogtay Shiraliyev and his deputies, as well as other health officials, were among the first to be vaccinated by what Shahmar Movsumov, an assistant to the president of Azerbaijan, earlier described as "the most safe and effective vaccine" procured by Azerbaijan.

Specialists decided that "the best vaccine for Azerbaijan is the vaccine of the Sinovac company" as it has passed clinical tests in many countries, said Shiraliyev, when addressing the local media after his inoculation in Baku.

The first stage of mass vaccination starting on Jan. 18 will cover health and technical workers at the country's medical institutions, law enforcement staff and servicemen, while people aged over 65 will be vaccinated starting from Feb. 1, according to health authorities.

Last week, Azerbaijan's Cabinet of Ministers approved the country's national COVID-19 vaccination strategy for 2021-2022, under which people who get the COVID-19 jab will receive a certificate to show they have been vaccinated.

Azerbaijan purchased 4 million doses of Sinovac vaccine, the first batch of which has been recently delivered to the country.

Although a strict special quarantine regime remains in effect throughout Azerbaijan until April 1, the authorities lifted major restrictions last weekend due to a drop in the number of infections in recent weeks.

According to the country's operational headquarters for COVID-19 prevention and control, Azerbaijan reported on Sunday 322 new cases in the last 24 hours, bringing its total to 227,273.
 
Pakistan approves China's Sinopharm COVID-19 vaccine for emergency use
Source: Xinhua| 2021-01-19 11:37:28|Editor: huaxia

139679907_16110274478521n.jpg
A staff member checks the packaging quality of COVID-19 inactivated vaccine products at a packaging plant of the Beijing Biological Products Institute Co., Ltd., a subsidiary of Chinese pharmaceutical firm Sinopharm, in Beijing Dec. 25, 2020. (Xinhua/Zhang Yuwei)

The Drug Regulatory Authority of Pakistan (DRAP) has approved a vaccine by China's Sinopharm for emergency use amid rising cases of COVID-19 in the country.

ISLAMABAD, Jan. 19 (Xinhua) -- The Drug Regulatory Authority of Pakistan (DRAP) has approved a vaccine by China's Sinopharm for emergency use amid rising cases of COVID-19 in the country.

A handout by DRAP on its official website late Monday read that Sinopharm, one of the two vaccines approved by the authority, has been given emergency use authorization after evaluating its safety and quality.

The authority said the authorization will be reviewed every quarter keeping in view further data regarding safety, efficacy and quality.

139679907_16110274478531n.jpg
People wearing face masks walk on a road in Rawalpindi of Pakistan's Punjab province on Jan. 10, 2021. (Xinhua/Ahmad Kamal)

A vaccine manufactured by British-Swedish pharmaceutical company AstraZeneca has also been given the authorization earlier, the handout said.

Chaudhry Fawad Hussain, the country's minister for science and technology, told Xinhua earlier that the Sinopharm vaccine has been approved for procurement by a cabinet committee for its safety and affordability.

Pakistan reported 1,920 new coronavirus infections and 46 deaths on Monday, bringing the total number of cases to 521,211 with 10,997 deaths.
 
CCTV+ @CCTV_Plus
China state-affiliated media

#Serbia became the first #European country to begin a mass #vaccination program with a Chinese-made #COVID19Vaccine after it inoculations of the #Sinopharm COVID-19 drug began on Tuesday.

CCTV+ @CCTV_Plus
China state-affiliated media

#Iraq has approved the emergency use of Chinese #Sinopharm #COVID19Vaccine to contain the spread of the #coronavirus pandemic, the country's health ministry said in a statement on Tuesday.
 
Back
Top Bottom